View New Articles By
Former Damon Runyon Fellow Aaron D. Viny, MD, cares for people with leukemia and myelodysplastic syndrome (MDS) at Memorial Sloan Kettering as an oncologist specializing in blood cancers. Recently, Dr. Viny spent two weeks treating cancer patients in the midst of the COVID-19 pandemic. Here are his reflections, from his twitter thread, as a physician-scientist at a unique time in medical history.
Co-Authored by Damon Runyon Fellow Caroline Bartman, PhD, and Sponsor Joshua Rabinowitz, MD, PhD, and published in the New York Times
As with any other poison, viruses are usually deadlier in larger amounts.
We’re thrilled to welcome Judy Swanson to the Damon Runyon Board of Directors this year. Judy is passionate about encouraging science and innovation at all levels, which is one of the reasons she supports Damon Runyon. Judy has been a member of the Damon Runyon Bay Area Committee since January 2017.
While parents have been coaxing kids to eat more vegetables for generations, only recently have researchers delved into understanding the science behind the health benefits. Elizabeth S. Sattely, PhD (Damon Runyon Fellow ‘08-‘10), has been at the forefront of this trend to harness plant chemistry to improve human health.
From all of us at the Damon Runyon Cancer Research Foundation, we sincerely hope that you are safe and healthy. We are aware that everyone is affected by COVID-19/novel coronavirus, from our scientists to our donors.
Advances in Genome Biology and Technology (AGBT) and the Damon Runyon Cancer Research Foundation have partnered to award a new fellowship in honor of world-renowned genomics pioneer, Elaine R. Mardis, PhD. Steven W. M. Crossley, PhD, at the University of California, Berkeley, will receive this award during the AGBT General Meeting to be held February.
Written by Yung S. Lie, PhD, President and Chief Executive Officer, Damon Runyon Cancer Research Foundation
Twenty-two brilliant early career investigators will receive funding to pursue cutting-edge cancer research.
This year the William Raveis Charitable Fund sponsors five outstanding young scientists, committing $450,000 to innovative projects with the greatest potential to impact cancer research. This support helps us foster the next generation of brave and bold scientists and fill gaps in traditional research funding that threaten future breakthroughs.
The Damon Runyon Cancer Research Foundation announced that 12 scientists with novel approaches to fighting cancer have been named 2020 recipients of the Damon Runyon-Rachleff Innovation Award. Six initial grants of $400,000 over two years will fund projects that have the potential to significantly impact the prevention, diagnosis and treatment of cancer. Each project demonstrating significant progres during the first two years of the award will have the opportunity for up to two additional years of funding (four years total for $800,000).
CONNECT
1.877.7CANCER
info@damonrunyon.org
One Exchange Plaza
55 Broadway, Suite 302
New York, NY 10006
